Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1999-11-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.96.23.13351PMID 10557324PMCID PMC23951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.

  1998cited by this paper
• Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production.

  1998cited by this paper
• IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.

  1998cited by this paper
• Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.

  1998cited by this paper
• Gene therapy for cancer: what have we done and where are we going?

  1997cited by this paper
• Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme

  1997cited by this paper
• Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

  1997cited by this paper
• Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

  1997cited by this paper
• Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme.

  1997cited by this paper
• IL-12 induces T helper 1-directed antitumor response.

  1997cited by this paper
• Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.

  1997cited by this paper
• Cytokine Gene Therapy of Cancer Using Gene Gun Technology: Superior Antitumor Activity of Interleukin-12

  1997cited by this paper
• IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.

  1997cited by this paper
• Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production

  1997cited by this paper
• In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites

  1997cited by this paper
• A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma.

  1997cited by this paper
• Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

  1997cited by this paper
• Combined chemokine and cytokine gene transfer enhances antitumor immunity

  1996cited by this paper
• Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.

  1996cited by this paper
• Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer.

  1996cited by this paper
• Immunotherapy of cancer with genetically modified tumor vaccines.

  1996cited by this paper
• IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.

  1996cited by this paper
• Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10.

  1996cited by this paper
• Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.

  1996cited by this paper
• Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells.

  1996cited by this paper
• Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.

  1996cited by this paper
• Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein.

  1996cited by this paper
• Particle-Mediated Gene Transfer of Granulocyte-Macrophage Colony-Stimulating Factor cDNA to Tumor Cells: Implications for a Clinically Relevant Tumor Vaccine

  1996cited by this paper
• Interferon‐γ‐inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin‐12 for interferon‐γ production

  1996cited by this paper
• Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12.

  1995cited by this paper
• Cloning of a new cytokine that induces IFN-γ production by T cells

  1995cited by this paper
• CD4 T cells inhibit in vivo the CD8‐mediated immune response against murine colon carcinoma cells transduced with interleukin‐12 genes

  1995cited by this paper
• A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock

  1995cited by this paper
• Sciencescope.

  1995cited by this paper
• Cloning of a new cytokine that induces IFN-gamma production by T cells.

  1995cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• In vivo cytokine gene transfer by gene gun reduces tumor growth in mice.

  1995cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

  1994cited by this paper
• The structure and complete nucleotide sequence of the murine gene encoding interleukin-1 beta converting enzyme (ICE).

  1994cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors

  1993cited by this paper
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

  1993cited by this paper
• Molecular cloning of the murine IL-1 beta converting enzyme cDNA.

  1992cited by this paper

• Interleukin-12 as an in situ cancer vaccine component: a review

  2022cites this paper
• Covalently assembled ultrathin polymer nanocapsules to mimic a multienzyme-cascade antioxidative system

  2020cites this paper
• Breast Cancer and Immunosenescence

  2019cites this paper
• Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model

  2019cites this paper
• Nucleic acid combinations: A new frontier for cancer treatment

  2017cites this paper
• Self-assembly of cricoid proteins induced by "soft nanoparticles": an approach to design multienzyme-cooperative antioxidative systems.

  2015cites this paper
• The Relationship between the Antitumor Effect of the IL-12 Gene Therapy and the Expression of Th1 Cytokines in an HPV16-Positive Murine Tumor Model

  2014cites this paper
• Association of interleukin‐18 promoter polymorphisms with chronic obstructive pulmonary disease in male smokers

  2013cites this paper
• Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity

  2012cites this paper
• Interleukin-18: the master regulator driving destructive and remodeling processes in the lungs of patients with chronic obstructive pulmonary disease?

  2012cites this paper
• DESIGNING AND CONSTRUCTION OF BICISTRONIC PLASMID PIRES-IGK/MIL18/FC: POTENTIAL IMPLICATIONS FOR VACCINE INVESTIGATIONS

  2011cites this paper
• Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα

  2011cites this paper
• Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα

  2011cites this paper
• Topical application of marine briarane-type diterpenes effectively inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and dermatitis in murine skin

  2011cites this paper
• Differential proteomic profiling identifies novel molecular targets of paclitaxel and phytoagent deoxyelephantopin against mammary adenocarcinoma cells.

  2010cites this paper
• Interleukin-18: biology and role in the immunotherapy of cancer.

  2010cites this paper
• Mechanisms of T cell mediated kidney disease

  2009cites this paper
• Immunosenescence and cancer vaccines

  2009cites this paper
• Purification and Characterization of the Mda-7 Tumor Suppressor Protein Expressed in Insect Cells

  2008cites this paper
• The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals.

  2008cites this paper
• Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells.

  2008cites this paper
• Purification and characterization of the mda-7 tumor suppressor protein expressed in insect cells

  2008cites this paper
• Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases.

  2007cites this paper
• Nonviral Vector Systems

  2007cites this paper
• Synergistic antileukemia effect of combinational gene therapy using murine b-defensin 2 and IL-18 in L1210 murine leukemia model

  2007cites this paper
• Cytokine Gene Therapy for Genitourinary Cancer

  2007cites this paper
• Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model

  2007cites this paper
• Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial

  2007cites this paper
• Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.

  2007cites this paper
• Inhibition of murine K-BALB and CT26 tumour growth using a Semliki Forest virus vector with enhanced expression of IL-18.

  2006cites this paper
• Caspase-1 as a radio- and chemo-sensitiser in vitro and in vivo.

  2006cites this paper
• Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver.

  2006cites this paper
• Cloning and characterization of a new isoform of mouse interleukin-18.

  2005cites this paper
• Treatment of experimental hepatic fibrosis by combinational delivery of urokinase‐type plasminogen activator and hepatocyte growth factor genes

  2005cites this paper
• Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity.

  2005cites this paper
• Naked DNA for liver gene transfer.

  2005cites this paper
• Technology evaluation: SB-485232, GlaxoSmithKline.

  2005cites this paper
• Immunoprevention and immunotherapy of cancer in ageing

  2005cites this paper
• Molecular strategies for improving cytokine transgene expression in normal and malignant tissues

  2004cites this paper
• Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma.

  2004cites this paper
• IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.

  2004cites this paper
• Gene transfer of pro-IL-18 and IL-1β converting enzyme cDNA induces potent antitumor effects in L1210 cells

  2004cites this paper
• Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity

  2004cites this paper
• Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention.

  2004cites this paper
• Interferon-gamma and TRAIL in human breast tumor cells.

  2004cites this paper
• IP‐10‐encoding plasmid DNA therapy exhibits anti‐tumor and anti‐metastatic efficiency

  2004cites this paper
• Immunotherapy by gene transfer with plasmids encoding IL-12/IL-18 is superior to IL-23/IL-18 gene transfer in a rat osteosarcoma model.

  2004cites this paper
• Expression of bioactive human interferon-gamma in transgenic rice cell suspension cultures

  2004cites this paper
• Bioactivity and secretion of interleukin-18 (IL-18) generated by equine and feline IL-18 expression constructs.

  2004cites this paper
• Cytokine-induced inflammatory liver injuries.

  2003cites this paper
• The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.

  2003cites this paper
• Evaluation of interleukin-12-induced interferon-y production in vitro by peripheral blood mononuclear cells in patients with chronic liver disease.

  2003cites this paper
• Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy.

  2003cites this paper
• Gene Transfer to Subdermal Tissues via a New Gene Gun Design

  2003cites this paper
• Identification of metastasis‐associated proteins by proteomic analysis and functional exploration of interleukin‐18 in metastasis

  2003cites this paper
• Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site

  2003cites this paper
• Pathophysiological roles for IL-18 in inflammatory arthritis

  2003cites this paper
• Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth.

  2003cites this paper
• Developing immunotherapy strategies for cancer treatment.

  2003cites this paper
• The Cytotoxic T-Lymphocyte Response against a Poorly Immunogenic Mammary Adenocarcinoma Is Focused on a Single Immunodominant Class I Epitope Derived from the gp 70 Env Product of an Endogenous Retrovirus 1

  2003cites this paper
• Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model.

  2002cites this paper
• Combined Administration of IL-18 and IL-2 byFas-Ligand-Dependent Tumor Eradication and γ and Induction of IFN-Endogenous Anti-Tumor Immune Response Synergistic Engagement of an Ineffective

  2002cites this paper
• Expression of ST2 in helper T lymphocytes of malignant pleural effusions.

  2002cites this paper
• Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.

  2002cites this paper
• Synergistic Engagement of an Ineffective Endogenous Anti-Tumor Immune Response and Induction of IFN-γ and Fas-Ligand-Dependent Tumor Eradication by Combined Administration of IL-18 and IL-21

  2002cites this paper
• Cationic lipids in gene delivery: principles, vector design and therapeutical applications.

  2002cites this paper
• Expression of interleukin‐18 in human ovarian carcinoma and normal ovarian epithelium: Evidence for defective processing in tumor cells

  2002cites this paper
• The Use of Particle-Mediated Gene Transfer for Immunotherapy of Cancer

  2002cites this paper
• Retracted: Enhanced Inhibition of Tumour Growth and Metastasis, and Induction of Antitumour Immunity by IL‐2‐IgG2b Fusion Protein

  2002cites this paper
• Current gene therapy for stomach carcinoma.

  2001cites this paper
• Clinical approaches to vaccination in oncology

  2001cites this paper
• Antitumor Immunity Induced by Irradiated Tumor Cells Producing Macrophage Colony-Stimulating Factor

  2001cites this paper
• Interleukin 12 Gene Transfer into Skin Distant from the Tumor Site Elicits Antimetastatic Effects Equivalent to Local Gene Transfer

  2001cites this paper
• Suppression of Immune Response and Protective Immunity to a Japanese Encephalitis Virus DNA Vaccine by Coadministration of an IL-12-Expressing Plasmid1

  2001cites this paper
• Systemic production of IL‐12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo

  2001cites this paper
• Interleukin-18 regulates both Th1 and Th2 responses.

  2001cites this paper
• In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice

  2001cites this paper
• Plasmid Coadministration of an IL-12-Expressing Encephalitis Virus DNA Vaccine by Protective Immunity to a Japanese Suppression of Immune Response and

  2001cites this paper
• Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

  2001cites this paper
• 131 Gene Therapy for Thyroid Cancer : Where Do We Stand ?

  2001cites this paper
• Immunological therapy of human tumors by gene-modified cellular vaccines.

  2000cites this paper
• Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model

  2000cites this paper
• Cytokine Gene Therapy for Cancer with Naked DNA

  2000cites this paper
• Interleukin 18 Restores Defective Th1 Immunity to Candida albicans in Caspase 1-Deficient Mice

  2000cites this paper
• Immunomodulation of cancer: potential use of selectively replicating agents.

  2000cites this paper
• Cytokine-secreting tumor cell vaccines.

  2000cites this paper
• Thérapie génique cutanée : acquis et perspectives.

  2000cites this paper
• Nonviral Skin Gene Therapy

  2000cites this paper
• Succinamide inhibitors of IL-1β converting enzyme

  2000cites this paper